Apr 25 |
Gilead (GILD) Reports Q1 Earnings: What Key Metrics Have to Say
|
Apr 25 |
Gilead Beats Earnings Expectations After Rocky Quarter
|
Apr 25 |
Gilead Sciences Inc (GILD) Q1 2024 Earnings: Misses Analyst EPS Estimates Amid Significant ...
|
Apr 25 |
Gilead Sciences (GILD) Reports Q1 Loss, Tops Revenue Estimates
|
Apr 25 |
Gilead Notches A Quarterly Beat On The Back Of Its Covid Drug, Again
|
Apr 25 |
Gilead Sciences in charts: Revenue from oncology rises most among products; Veklury dips in Q1
|
Apr 25 |
Gilead posts quarterly loss on acquisition charge, revenue rises 5%
|
Apr 25 |
Gilead Sciences Non-GAAP EPS of -$1.32 beats by $0.20, revenue of $6.69B beats by $350M
|
Apr 25 |
Gilead Sciences Announces First Quarter 2024 Financial Results
|
Apr 25 |
US Stocks Brace For Negative Start Amid Tech Earnings Disappointments, Caution Ahead Of Data: 'Worst Of This Two-Week Decline Is Behind Us,' Says Analyst
|